SCHEMBL418184

SCHEMBL418184

C[C@@H]1CCC(=O)C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1523123 1.00
SCHEMBL106510 1.00
SCHEMBL7908923 0.88 KMT2A (0.46)
SCHEMBL22235813 0.88 TRIM24 (0.50)
SCHEMBL19420080 0.87 CRBN (0.39)
SCHEMBL9490715 0.86 TRIM24 (0.38)
Formic Acid Methyl Ester SCHEMBL28134186 0.84 TLR4 (0.33)
SCHEMBL22708 0.83
SCHEMBL38785 0.83
SCHEMBL857124 0.83

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 126 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050215816-A1 Cyclic ketones, their preparation and their use in the synthesis of amino acids BLAKEMORE DAVID C 2005-09-29 US claimed
US-6872856-B2 Cyclic ketones, their preparation and their use in the synthesis of amino acids WARNER-LAMBERT COMPANY (US) 2005-03-29 US claimed
US-20030187296-A1 Cyclic ketones, their preparation and their use in the synthesis of amino acids WARNER-LAMBERT COMPANY 2003-10-02 US claimed
EP-1296921-A1 CYCLIC KETONES, THEIR PREPARATION AND THEIR USE IN THE SYNTHESIS OF AMINO ACIDS WARNER-LAMBERT COMPANY (US) 2003-04-02 EP claimed
WO-2002000584-A1 CYCLIC KETONES, THEIR PREPARATION AND THEIR USE IN THE SYNTHESIS OF AMINO ACIDS WARNER-LAMBERT COMPANY (US) 2002-01-03 WO claimed
US-11708371-B2 Process for making beta 3 agonists and intermediates MERCK SHARP & DOHME CORP. (US) 2023-07-25 US disclosed
EP-3313362-B1 MUSK COMPOSITIONS AND METHODS OF USE THEREOF TAKASAGO PERFUMERY CO LTD (JP) 2022-02-09 EP disclosed
US-11198699-B2 Compounds targeting PRMT5 ALIGOS THERAPEUTICS, INC. (US) 2021-12-14 US disclosed
CN-113710785-A Compound and detergent composition 联合利华知识产权控股有限公司 2021-11-26 CN disclosed
US-20200317686-A1 COMPOUNDS TARGETING PRMT5 ALIGOS THERAPEUTICS, INC. 2020-10-08 US disclosed
US-20180334436-A1 TETRAHYDROISOQUINOLINE DERIVATIVES VIIV HEALTHCARE UK LIMITED (GB) 2018-11-22 US disclosed
EP-3383866-A1 TETRAHYDROISOQUINOLINE DERIVATIVES ViiV Healthcare UK Limited (GB) 2018-10-10 EP disclosed
WO-2000014236-A2 GRF ANALOGS WITH INCREASED BIOLOGICAL POTENCY THERATECHNOLOGIES INC. (CA) 2000-03-16 WO disclosed
US-5998616-A Biocatalyst for the conversion of carbonyl compounds to their β-unsaturated derivatives using molecular oxygen as the oxidant THE UNIVERSITY OF MICHIGAN (US) 1999-12-07 US disclosed
EP-0724570-B1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS SEARLE & CO (US) 1999-03-03 EP disclosed
EP-0897912-A1 Amidino derivatives useful as nitric oxide synthase inhibitors G.D. SEARLE & CO. (US) 1999-02-24 EP disclosed
US-5854234-A Amidino dervatives useful as nitric oxide synthase inhibitors G. D. SEARLE & CO. (US) 1998-12-29 US disclosed
EP-0818431-A1 Scavenger assisted combinatorial process for preparing libaries of secondary amine compounds ELI LILLY AND COMPANY (US) 1998-01-14 EP disclosed
EP-0724570-A1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G.D. SEARLE & CO. (US) 1996-08-07 EP disclosed
WO-1995011231-A1 AMIDINO DERIVATIVES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS G. D. SEARLE & CO. (US) 1995-04-27 WO disclosed